{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:25:49Z","timestamp":1792898749823,"version":"4.5.0"},"reference-count":42,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R41AI172485-01A1"],"award-info":[{"award-number":["1R41AI172485-01A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Norovirus is a leading cause of epidemic acute gastroenteritis worldwide, associated with significant morbidity, mortality, and economic loss. Despite its global impact, no licensed vaccine is currently available, and vaccine development remains challenging. Methods: We explored avian immunoglobulin Y (IgY) antibodies as a low-cost countermeasure against norovirus infection. We generated recombinant protruding (P) domain proteins from the capsid protein (VP1) of noroviruses, representing two GII.4 variants and the GII.6 genotype. These were combined into a single immunogen to immunize laying hens to produce norovirus VP1-specific IgY antibodies. Results: Immunization of laying hens with the P domain proteins elicited high-titer (&gt;1:450,000) P domain-specific IgY antibodies. The yolk-derived IgY effectively inhibited binding of various norovirus P particles to their histo-blood group antigen ligands, with 50% blocking titers (BT50) up to 1:8533 against homotypic GII.4 and 1:667 against heterotypic G1.1 Norwalk virus P particles. Importantly, the IgY neutralized replication of GII.4 norovirus in the human intestinal enteroid (HIE) system at a high titer of over 1:2500, equivalent to 0.70 \u00b5g\/mL of total IgY. We also produced norovirus shell (S) domain proteins and corresponding IgY antibodies, which neutralized GII.4 norovirus replication in the HIE model at a titer of ~1:800, equivalent to 2.98 \u00b5g\/mL of total IgY. This provides the first evidence that the S domain contains neutralizing epitopes. Conclusions: Our findings support the potential of IgY targeting norovirus P or S domains as a scalable, cost-effective strategy for preventing norovirus infection and disease.<\/jats:p>","DOI":"10.3390\/vaccines13121228","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T13:17:07Z","timestamp":1764940627000},"page":"1228","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Avian Immunoglobulin Y Antibodies Targeting the Protruding or Shell Domain of Norovirus Capsid Protein Neutralize Norovirus Replication in the Human Intestinal Enteroid System"],"prefix":"10.3390","volume":"13","author":[{"given":"Ming","family":"Xia","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH 45229, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ichou","sequence":"additional","affiliation":[{"name":"Evimero, 100 Rice Mine Road Loop, Suite 301, Tuscaloosa, AL 35406, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathew","family":"Landivar","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24060, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24060, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Navya","family":"Vadlamudi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24060, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Leruth","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24060, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Nyblade","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24060, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cox","sequence":"additional","affiliation":[{"name":"Evimero, 100 Rice Mine Road Loop, Suite 301, Tuscaloosa, AL 35406, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0709-5228","authenticated-orcid":false,"given":"Lijuan","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24060, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9449-968X","authenticated-orcid":false,"given":"Julius","family":"Goepp","sequence":"additional","affiliation":[{"name":"Evimero, 100 Rice Mine Road Loop, Suite 301, Tuscaloosa, AL 35406, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6489-5507","authenticated-orcid":false,"given":"Ming","family":"Tan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, OH 45229, USA"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1128\/CMR.00075-14","article-title":"Norovirus","volume":"28","author":"Robilotti","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_2","first-page":"841","article-title":"Human Calicivirus","volume":"Volume 2","author":"Knipe","year":"2001","journal-title":"Fields Virology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41541-024-00884-2","article-title":"A narrative review of norovirus epidemiology, biology, and challenges to vaccine development","volume":"9","author":"Carlson","year":"2024","journal-title":"npj Vaccines"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41579-024-01144-9","article-title":"Norovirus replication, host interactions and vaccine advances","volume":"23","author":"Prasad","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1017\/S0950268817002692","article-title":"Norovirus transmission dynamics: A modelling review","volume":"146","author":"Gaythorpe","year":"2018","journal-title":"Epidemiol. Infect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1017\/S095026881300006X","article-title":"Norovirus outbreaks: A systematic review of commonly implicated transmission routes and vehicles","volume":"141","author":"Bitler","year":"2013","journal-title":"Epidemiol. Infect."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/cid\/ciy985","article-title":"Birth Cohort Studies Assessing Norovirus Infection and Immunity in Young Children: A Review","volume":"69","author":"Cannon","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Lindsay, L., Wolter, J., De Coster, I., Van Damme, P., and Verstraeten, T. (2015). A decade of norovirus disease risk among older adults in upper-middle and high income countries: A systematic review. BMC Infect. Dis., 15.","DOI":"10.1186\/s12879-015-1168-5"},{"key":"ref_9","first-page":"20499361221136760","article-title":"Norovirus disease among older adults","volume":"9","author":"Tsai","year":"2022","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/1469-0691.12761","article-title":"Norovirus infection in immunocompromised hosts","volume":"20","author":"Green","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Pires, S.M., Fischer-Walker, C.L., Lanata, C.F., Devleesschauwer, B., Hall, A.J., Kirk, M.D., Duarte, A.S., Black, R.E., and Angulo, F.J. (2015). Aetiology-Specific Estimates of the Global and Regional Incidence and Mortality of Diarrhoeal Diseases Commonly Transmitted through Food. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0142927"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1473-3099(14)70767-4","article-title":"Global prevalence of norovirus in cases of gastroenteritis: A systematic review and meta-analysis","volume":"14","author":"Ahmed","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bartsch, S.M., Lopman, B.A., Ozawa, S., Hall, A.J., and Lee, B.Y. (2016). Global Economic Burden of Norovirus Gastroenteritis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151219"},{"key":"ref_14","unstructured":"CDC (2025). Norovirus Facts and Stats, CDC."},{"key":"ref_15","unstructured":"NoroSTAT (2025). NoroSTAT Data, CDC."},{"key":"ref_16","unstructured":"CaliciNet (2025). CaliciNet Data, CaliciNet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3201\/eid3107.250524","article-title":"Increasing Predominance of Norovirus GII.17 over GII.4, United States, 2022\u20132025","volume":"31","author":"Barclay","year":"2025","journal-title":"Emerg. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"eadh9906","DOI":"10.1126\/scitranslmed.adh9906","article-title":"An oral norovirus vaccine generates mucosal immunity and reduces viral shedding in a phase 2 placebo-controlled challenge study","volume":"17","author":"Flitter","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"ref_19","unstructured":"Vaxart (2023). Vaxart Announces Topline Data from the Phase 2 Challenge Study of its Monovalent Norovirus Vaccine Candidate, Vaxart."},{"key":"ref_20","unstructured":"HilleVax (2024). HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants, HilleVax."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1126\/science.286.5438.287","article-title":"X-ray crystallographic structure of the Norwalk virus capsid","volume":"286","author":"Prasad","year":"1999","journal-title":"Science"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/JVI.01835-10","article-title":"Norovirus P particle, a novel platform for vaccine development and antibody production","volume":"85","author":"Tan","year":"2011","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"10665","DOI":"10.1021\/acsnano.8b02776","article-title":"Bioengineered Norovirus S60 Nanoparticles as a Multifunctional Vaccine Platform","volume":"12","author":"Xia","year":"2018","journal-title":"ACS Nano"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Lee, L., Samardzic, K., Wallach, M., Frumkin, L.R., and Mochly-Rosen, D. (2021). Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.696003"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.aaf5211","article-title":"Replication of human noroviruses in stem cell-derived human enteroids","volume":"353","author":"Ettayebi","year":"2016","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e0044824","DOI":"10.1128\/msphere.00448-24","article-title":"Insights into human norovirus cultivation in human intestinal enteroids","volume":"9","author":"Ettayebi","year":"2024","journal-title":"mSphere"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1128\/JVI.78.12.6233-6242.2004","article-title":"The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors","volume":"78","author":"Tan","year":"2004","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14017","DOI":"10.1128\/JVI.79.22.14017-14030.2005","article-title":"The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors","volume":"79","author":"Tan","year":"2005","journal-title":"J. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.1021\/acsnano.4c00544","article-title":"A Viral Protein 4-Based Trivalent Nanoparticle Vaccine Elicited High and Broad Immune Responses and Protective Immunity against the Predominant Rotaviruses","volume":"18","author":"Xia","year":"2024","journal-title":"ACS Nano"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Artman, C., Brumfield, K.D., Khanna, S., and Goepp, J. (2021). Avian antibodies (IgY) targeting spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibit receptor binding and viral replication. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0252399"},{"key":"ref_31","first-page":"e3084","article-title":"IgY technology: Extraction of chicken antibodies from egg yolk by polyethylene glycol (PEG) precipitation","volume":"51","author":"Pauly","year":"2011","journal-title":"J. Vis. Exp. JoVE"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1073\/pnas.1910138117","article-title":"Bile acids and ceramide overcome the entry restriction for GII.3 human norovirus replication in human intestinal enteroids","volume":"117","author":"Murakami","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e0202023","DOI":"10.1128\/jvi.02020-23","article-title":"Bile acid-sensitive human norovirus strains are susceptible to sphingosine-1-phosphate receptor 2 inhibition","volume":"98","author":"Tenge","year":"2024","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1038\/s41467-023-42146-0","article-title":"A single nanobody neutralizes multiple epochally evolving human noroviruses by modulating capsid plasticity","volume":"14","author":"Salmen","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/656364","article-title":"Serological correlate of protection against norovirus-induced gastroenteritis","volume":"202","author":"Reeck","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Lindesmith, L.C., Ferris, M.T., Mullan, C.W., Ferreira, J., Debbink, K., Swanstrom, J., Richardson, C., Goodwin, R.R., Baehner, F., and Mendelman, P.M. (2015). Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: Immunological analyses from a phase I clinical trial. PLoS Med., 12.","DOI":"10.1371\/journal.pmed.1001807"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/CVI.00196-15","article-title":"Serological Correlates of Protection against a GII.4 Norovirus","volume":"22","author":"Atmar","year":"2015","journal-title":"Clin. Vaccine Immunol. CVI"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/infdis\/jiaa116","article-title":"Genotype-Specific Neutralization of Norovirus Is Mediated by Antibodies Against the Protruding Domain of the Major Capsid Protein","volume":"225","author":"Wales","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41586-018-0852-1","article-title":"Calicivirus VP2 forms a portal-like assembly following receptor engagement","volume":"565","author":"Conley","year":"2019","journal-title":"Nature"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Khanna, M., Sharma, S., Kumar, B., and Rajput, R. (2014). Protective immunity based on the conserved hemagglutinin stalk domain and its prospects for universal influenza vaccine development. Biomed. Res. Int., 2014.","DOI":"10.1155\/2014\/546274"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/mi.2014.59","article-title":"Targeting the HA2 subunit of influenza A virus hemagglutinin via CD40L provides universal protection against diverse subtypes","volume":"8","author":"Fan","year":"2015","journal-title":"Mucosal Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Dong, C., and Wang, B.Z. (2024). Advancing universal influenza vaccines: Insights from cellular immunity targeting the conserved hemagglutinin stalk domain in humans. EBioMedicine, 104.","DOI":"10.1016\/j.ebiom.2024.105172"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/12\/1228\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T13:57:25Z","timestamp":1764943045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/12\/1228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["vaccines13121228"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13121228","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]}}}